Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -60.08% is 11% above its 4-year average of -67.17%, around the middle of its 4-year range (-147.61%–-6.61%).
49.76% above its 12-month average of -119.59%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -36.14%.
RETURN ON ASSETS (ROA)
-60.08%
RETURN ON ASSETS (ROA) AVG TTM
-119.59%
RETURN ON ASSETS (ROA) AVG 3Y
-67.97%
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+49.76%
CURRENT VS 3Y AVG
+11.60%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-86.35%
vs the sector median at left
QT Imaging Holdings, Inc.
Market Cap
$35.52M
Return on Assets (ROA)
-60.08%
TTM Avg
-119.59%
3Y Avg
-67.97%
5Y Avg
N/A
Market Cap
$35.76M
Return on Assets (ROA)
-103.00%
TTM Avg
-39.81%
3Y Avg
-17.36%
5Y Avg
-12.69%
Market Cap
$35.84M
Return on Assets (ROA)
-110.85%
TTM Avg
-107.44%
3Y Avg
-115.17%
5Y Avg
-101.88%
Market Cap
$35.84M
Return on Assets (ROA)
-120.78%
TTM Avg
-168.59%
3Y Avg
-147.82%
5Y Avg
-131.31%
Market Cap
$34.97M
Return on Assets (ROA)
-136.91%
TTM Avg
-90.70%
3Y Avg
-79.79%
5Y Avg
-214.88%
Market Cap
$36.21M
Return on Assets (ROA)
-277.36%
TTM Avg
-524.61%
3Y Avg
-478.10%
5Y Avg
-316.43%
Market Cap
$34.35M
Return on Assets (ROA)
118.69%
TTM Avg
-31.86%
3Y Avg
-49.56%
5Y Avg
-43.59%
Market Cap
$33.63M
Return on Assets (ROA)
-176.33%
TTM Avg
-88.31%
3Y Avg
-79.12%
5Y Avg
-81.37%
Market Cap
$33.61M
Return on Assets (ROA)
-42.84%
TTM Avg
-15.31%
3Y Avg
-31.73%
5Y Avg
-29.34%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| QT Imaging Holdings, Inc. (QTI) | $35.52M | -60.08% | -119.59% | -67.97% | N/A |
| DocGo Inc. (DCGO)vs › | $35.76M | -103.00% | -39.81% | -17.36% | -12.69% |
| Edesa Biotech, Inc. (EDSA)vs › | $35.84M | -110.85% | -107.44% | -115.17% | -101.88% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $35.84M | -120.78% | -168.59% | -147.82% | -131.31% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.97M | -136.91% | -90.70% | -79.79% | -214.88% |
| EUDA Health Holdings Limited (EUDA)vs › | $36.21M | -277.36% | -524.61% | -478.10% | -316.43% |
| Elutia Inc (ELUT)vs › | $34.35M | 118.69% | -31.86% | -49.56% | -43.59% |
| Scilex Holding Company (SCLX)vs › | $33.63M | -176.33% | -88.31% | -79.12% | -81.37% |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.61M | -42.84% | -15.31% | -31.73% | -29.34% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.29M | -114.53% | -107.26% | -84.46% | -72.21% |
ROA
-60.1%
ROE
-819.3%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -91.58% |
| 2024-12-31 | -147.61% |
| 2023-12-31 | -26.07% |
| 2022-12-31 | -6.61% |
| 2021-12-31 | -64.00% |
